OTCM
HDRPF
Market cap6mUSD
Nov 03, Last price
0.00USD
Name
Epsilon Healthcare Ltd
Chart & performance
P/E
—
P/S
0.08
EPS
—
Vol. 1Y
—
Shs. 5Y
19.03%
Rev. 5Y
5.00%
Div Yld LY
—
Div Yld TTM
—
Revenues
9m
+67.74%
Net income
-1m
L-60.62%
CFO
-3m
L-8.19%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Epsilon Healthcare Limited functions as a health and pharmaceuticals enterprise with core operations spanning Australia and Canada. The company's activities encompass the manufacturing and supply of hydroponic equipment, materials, and specialized nutrient solutions. Furthermore, it focuses on the development and distribution of medicinal cannabis products, alongside providing comprehensive, turnkey cultivation systems for the plant. Established in 2016, the firm is headquartered in Sydney, Australia. Epsilon Healthcare Limited adopted its current identity in February 2021, having previously been known as THC Global Group Limited.
Key people
Non-Executive Chairman of the Board · since 2024
Peter Giannopoulos
Group Chief Executive Officer, Managing Director, Executive Director · since 2024
Daniel Kaplon
Chief Financial Officer · since 2025
Lin Li
Group Financial Controller · since 2022
Jason Colquhoun
Key Management Personnel
Laura Harvey
Key Management Personnel
Diandra Phipps
Key Management Personnel
Marcelo Mora
Company Secretary · since 2022
Zoe Hutchings
Non-Executive Director · since 2024
Headquarters & legal address
Level 2, 131 Macquarie Street
Sydney, NSW 2000
AU
Sydney, NSW 2000
AU
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||